Hypothyroidism and Osgood-schlatter disease

Summary:

Osgood-schlatter disease is found among people with Hypothyroidism, especially for people who are female, 60+ old.

The study analyzes which people have Osgood-schlatter disease with Hypothyroidism. It is created by eHealthMe based on reports of 17 people who have Hypothyroidism from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 03, 2023

17 people who have Hypothyroidism and Osgood-Schlatter Disease are studied.

What is Hypothyroidism?

Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development) is found to be associated with 2,862 drugs and 2,423 conditions by eHealthMe.

What is Osgood-schlatter disease?

Osgood-schlatter disease (an overuse injury that occurs in the knee area of growing adolescents. it is caused by inflammation of the tendon below the kneecap) is found to be associated with 658 drugs and 282 conditions by eHealthMe.

Number of Osgood-schlatter disease in Hypothyroidism reports submitted per year:

Would you have Osgood-schlatter disease when you have Hypothyroidism?

Gender of people who have Hypothyroidism and experienced Osgood-Schlatter Disease *:

female: 82.35 %
male: 17.65 %

Age of people who have Hypothyroidism and experienced Osgood-Schlatter Disease *:

Common co-existing conditions for these people *:

High Blood Pressure: 4 people, 23.53%
Pain: 4 people, 23.53%
Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 3 people, 17.65%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 3 people, 17.65%
Psoriasis (immune-mediated disease that affects the skin): 3 people, 17.65%
Osteoporosis (bones weak and more likely to break): 3 people, 17.65%
Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults): 3 people, 17.65%
Insomnia (sleeplessness): 3 people, 17.65%
Thyroid Diseases: 2 people, 11.76%
Blood Cortisol Decreased: 2 people, 11.76%

Common drugs taken by these people *:

Common symptoms for these people *:

Breathing Difficulty: 8 people, 47.06%
Headache (pain in head): 5 people, 29.41%
Oedema Peripheral (superficial swelling): 5 people, 29.41%
Abdominal Discomfort: 4 people, 23.53%
High Blood Pressure: 4 people, 23.53%
High Blood Cholesterol: 4 people, 23.53%
Nausea (feeling of having an urge to vomit): 4 people, 23.53%
Osteomyelitis (infection of bone): 4 people, 23.53%
Fatigue (feeling of tiredness): 4 people, 23.53%
Depression: 4 people, 23.53%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Osgood-schlatter disease?

Check whether Osgood-schlatter disease is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Ezeji GC, Inoue T, Bahtiyar G, Sacerdote A, "Hallucinations associated with miglitol use in a patient with chronic kidney disease and hypothyroidism", BMJ case reports, 2015 Feb .

Related studies

Treatments, associated drugs and conditions:

Hypothyroidism (149,174 reports)
Osgood-schlatter disease (1,696 reports)

COVID vaccines that are related to Osgood-schlatter disease:

Common drugs associated with Osgood-schlatter disease:

Humira: 135 reports
Pantoprazole: 110 reports
Zometa: 108 reports

How the study uses the data?

The study is based on Osgood-schlatter disease and Hypothyroidism, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.